NewsBenzingaQ32生物公司在欧洲皮肤病学和性病学学会大会上发布了Bempikibart SIGNAL-AA 2a期临床研究B部分的额外36周数据 Q32生物公司在欧洲皮肤病学和性病学学会大会上发布了Bempikibart SIGNAL-AA 2a期临床研究B部分的额外36周数据 Benzinga 2026.09.21 13:23 (GMT+0) Open on Benzinga Other news Here's How Much $1000 Invested In Analog Devices 20 Years Ago Would Be Worth Today RPC Says Richard A. Hubbell To Retire As Executive Chairman And Director Effective Dec 31, 2026 Neocloud Stocks Catch a Bid After Nvidia Q3 Beat NVIDIA Interim CEO Says Co.'s Q4 Sales Growth To Be Driven By AI Demand, Vera Rubin Rollout NVIDIA Interim CEO Says Co. Remains On Track To Launch Vera Rubin Ultra Next Year And Feynman In 2028 ReAlpha Tech Corp Q3 EPS $(0.60) Misses $(0.50) Estimate, Sales $1.604M Miss $5.644M Estimate
NVIDIA Interim CEO Says Co. Remains On Track To Launch Vera Rubin Ultra Next Year And Feynman In 2028